Ligand validation:3B29

GSH: GLUTATHIONE

GSH is a Ligand Of Interest in 3B29 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3B29_GSH_A_201	80%	56%	0.128	0.977	0.85	0.85	-	-	1	0	100%	1
2UUH_GSH_A_1150	94%	6%	0.082	0.983	2.41	2.73	5	9	2	1	100%	1
3LEO_GSH_A_212	89%	7%	0.099	0.98	2.57	2.29	2	9	0	1	100%	1
3PCV_GSH_A_201	85%	8%	0.091	0.956	2.69	1.89	2	6	0	0	100%	1
2PNO_GSH_F_206	67%	9%	0.16	0.968	3.09	1.41	2	4	2	0	100%	1
5HV9_GSH_A_201	18%	54%	0.245	0.829	0.69	1.08	-	1	1	0	100%	1
3R2Q_GSH_A_301	100%	42%	0.036	0.992	1.11	1.13	1	2	0	0	100%	0.952
7JR8_GSH_B_202	100%	32%	0.044	0.996	1.49	1.2	2	1	0	0	100%	1
8AGQ_GSH_A_301	100%	52%	0.046	0.99	0.91	0.96	-	-	0	0	100%	1
4MF6_GSH_A_301	99%	52%	0.051	0.99	1.16	0.72	2	-	0	0	100%	1
3C8E_GSH_B_289	99%	10%	0.051	0.983	2.53	1.77	3	6	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.